Investigational Site Number : 2760003

Mannheim 68167

0 studies enrolling now · 2 studies all time

What they study most

Malignant Melanoma, Metastatic Neoplasm, Squamous Cell Carcinoma of Skin

Studies at this site

• A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) — Stopped early
• A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors — Stopped early